Relapse of postpolycythemia myelofibrosis after allogeneic stem cell transplantation in a polycythemic phase: successful treatment with donor lymphocyte infusion directed by quantitative PCR test for V617F-JAK2 mutation

被引：0
作者：
O Benjamini
M Koren-Michowitz
N Amariglio
N Kroger
A Nagler
A Shimoni
机构：
[1] Chaim Sheba Medical Center,Division of Hematology and Bone Marrow Transplantation
来源：
Leukemia | 2008年 / 22卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1961 / 1963
页数：2
相关论文
共 50 条
  • [21] No impact of JAK2 gene mutation on the relapse risk after allogeneic haematopoietic stem cell transplantation in patients with myelofibrosis
    Ditschkowski, M
    Elmaagacli, AH
    Koldehoff, M
    Bicen, A
    Steckel, NK
    Trenschel, R
    Beelen, DW
    BONE MARROW TRANSPLANTATION, 2006, 37 : S232 - S232
  • [22] Successful treatment by donor lymphocyte infusion of adult T-cell leukemia/lymphoma relapse following allogeneic hematopoietic stem cell transplantation
    Kamimura, Tomohiko
    Miyamoto, Toshihiro
    Kawano, Noriaki
    Numata, Akihiko
    Ito, Yoshikiyo
    Chong, Yong
    Nagafuji, Koji
    Teshima, Takanori
    Hayashi, Shin
    Akashi, Koichi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2012, 95 (06) : 725 - 730
  • [23] Successful treatment by donor lymphocyte infusion of adult T-cell leukemia/lymphoma relapse following allogeneic hematopoietic stem cell transplantation
    Tomohiko Kamimura
    Toshihiro Miyamoto
    Noriaki Kawano
    Akihiko Numata
    Yoshikiyo Ito
    Yong Chong
    Koji Nagafuji
    Takanori Teshima
    Shin Hayashi
    Koichi Akashi
    International Journal of Hematology, 2012, 95 : 725 - 730
  • [24] Donor lymphocyte infusion ± alpha interferon for the treatment of relapse after allogeneic stem cell transplantation:: retrospective analyses of efficacy and toxicity
    Sponerova, D
    Lukasova, M
    Moravcova, J
    Vitek, A
    Klamova, H
    Sajdova, J
    BONE MARROW TRANSPLANTATION, 2003, 31 : S166 - S166
  • [25] Transformed essential thrombocytosis with a JAK2 V617F mutation relapsing as JAK2 mutation-negative leukaemia after allogeneic stem cell transplantation
    W Y Au
    A Fung
    K Y Lam
    A K Lie
    R Liang
    Y L Kwong
    Bone Marrow Transplantation, 2006, 38 : 573 - 574
  • [26] Transformed essential thrombocytosis with a JAK2 V617F mutation relapsing as JAK2 mutation-negative leukaemia after allogeneic stem cell transplantation
    Au, W. Y.
    Fung, A.
    Lam, K. Y.
    Lie, A. K.
    Liang, R.
    Kwong, Y. L.
    BONE MARROW TRANSPLANTATION, 2006, 38 (08) : 573 - 574
  • [27] Successful treatment with gemtuzumab ozogamicin and donor lymphocyte infusion for acute myeloid leukemia relapsing after allogeneic stem cell transplantation
    Takayoshi Tachibana
    Masatsugu Tanaka
    Hirotaka Takasaki
    Ayumi Numata
    Shin Fujisawa
    Atsuo Maruta
    Hiroshi Harada
    Hiraku Mori
    Yoshiaki Ishigatsubo
    Heiwa Kanamori
    International Journal of Hematology, 2011, 94 : 580 - 582
  • [28] Successful treatment with gemtuzumab ozogamicin and donor lymphocyte infusion for acute myeloid leukemia relapsing after allogeneic stem cell transplantation
    Tachibana, Takayoshi
    Tanaka, Masatsugu
    Takasaki, Hirotaka
    Numata, Ayumi
    Fujisawa, Shin
    Maruta, Atsuo
    Harada, Hiroshi
    Mori, Hiraku
    Ishigatsubo, Yoshiaki
    Kanamori, Heiwa
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2011, 94 (06) : 580 - 582
  • [29] Comparison of the DONOR Lymphocyte Infusion and Second Allogeneic STEM-CELL Transplantation in the Treatment of First Hematological Relapse after Allogeneic STEM-CELL Transplantation in Adults with ACUTE Leukemia
    Demiroglu, Haluk
    Aladag, Elifcan
    Chao, Nelson J.
    Buyukasik, Yahya
    Goker, Hakan
    BLOOD, 2019, 134
  • [30] Evading Capture by Residual Disease Monitoring: Extramedullary Manifestation of JAK2 V617F-Positive Primary Myelofibrosis After Allogeneic Stem Cell Transplantation
    Langabeer, Stephen E.
    Nolan, James
    Haslam, Karl
    Clarke, Lindsey
    Flavin, Richard
    Conneally, Eibhlin
    CASE REPORTS IN HEMATOLOGY, 2015, 2015
12345